AIDS-related morbidity and mortality has decreased greatly with the advent and use of highly active antiretroviral therapy (HAART). The incidence of some AIDS-defining cancers (Kaposi's sarcoma and non-Hodgkin's lymphoma) has declined significantly with the widespread use of HAART, while incidence rates of other cancers that are considered to be increased in HIV-infected people (including Hodgkin's disease, cervical cancer and anal cancer) have shown no change in the post-HAART era. To further explore the effect of HAART on cancer incidence at the population level, we propose to match San Francisco AIDS cases diagnosed for the years 1990 through 2000 with California cancer cases diagnosed for the years 1988 through 2000. This match will allow us to examine the effect of HAART on temporal trends in both AIDS-defining cancers and non-AIDS-defining cancer incidence among AIDS patients in San Francisco. We will compare the time before HAART was introduced (1988-Nov 1995) to the years when HAART was widely available (Nov 1995- 2000). In addition, we will assess cancer survival time with immunologic status and clinical presentation of both AIDS-defining and non-AIDS-defining cancers among AIDS patients who use HAART and those who do not. Changes in morbidity and mortality among persons with AIDS are readily apparent in San Francisco, a national metropolitan area with the third most cumulative AIDS cases and a city in which over three-fourths of persons with AIDS have received HAART. The completeness of AIDS case reporting in San Francisco is 97% and follow-up chart review of AIDS cases is completed every 18 months providing up-to-date information regarding treatment use and diagnoses with subsequent AIDS diagnoses. The California Cancer Registry is one of the largest cancer registries in the world with approximately 120,000 new cases reported each year and is internationally recognized for its high quality cancer data. The San Francisco Department of Public Health AIDS registry provides a complete population-based dataset of AIDS cases in San Francisco allowing us to evaluate the impact that HAART use and improved survival with AIDS has on subsequent development of cancers. Given the respective strengths of the AIDS and cancer registries, we are uniquely situated to perform these investigations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Research Grants (R03)
Project #
5R03AI055270-02
Application #
6738156
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Roe, Joanad'Arc C
Project Start
2003-05-01
Project End
2004-10-31
Budget Start
2004-05-01
Budget End
2004-10-31
Support Year
2
Fiscal Year
2004
Total Cost
$28,428
Indirect Cost
Name
San Francisco Department of Public Health
Department
Type
DUNS #
103717336
City
San Francisco
State
CA
Country
United States
Zip Code
94102
Uldrick, Thomas S; Pipkin, Sharon; Scheer, Susan et al. (2014) Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS 28:397-405
Pipkin, Sharon; Scheer, Susan; Okeigwe, Ijeoma et al. (2011) The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry. AIDS 25:463-71
Rinaldi, Gabriel; Suttiprapa, Sutas; Brindley, Paul J (2011) Quantitative retrotransposon anchored PCR confirms transduction efficiency of transgenes in adult Schistosoma mansoni. Mol Biochem Parasitol 177:70-6
Oke, Tolulope T; Moskovitz, Jackob; Williams, David L (2009) Characterization of the methionine sulfoxide reductases of Schistosoma mansoni. J Parasitol 95:1421-8
Hessol, Nancy A; Pipkin, Sharon; Schwarcz, Sandra et al. (2007) The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 165:1143-53
Jarusiewicz, Jamie A; Sherma, Joseph; Fried, Bernard (2006) Thin layer chromatographic analysis of glucose and maltose in estivated Biomphalaria glabrata snails and those infected with Schistosoma mansoni. Comp Biochem Physiol B Biochem Mol Biol 145:346-9
Singh, K P; Gerard, H C; Hudson, A P et al. (2006) Differential expression of collagen, MMP, TIMP and fibrogenic-cytokine genes in the granulomatous colon of Schistosoma mansoni-infected mice. Ann Trop Med Parasitol 100:611-20
Hu, Jerry S; Freeman, Christine M; Stolberg, Valerie R et al. (2006) AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation. Am J Pathol 169:424-32
Taylor, Justin J; Mohrs, Markus; Pearce, Edward J (2006) Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 176:5839-47
Williams, David L; Sayed, Ahmed A; Ray, Debalina et al. (2006) Schistosoma mansoni albumin, a major defense against oxidative damage, was acquired by lateral gene transfer from a mammalian host. Mol Biochem Parasitol 150:359-63

Showing the most recent 10 out of 85 publications